| (Values in U.S. Thousands) | Sep, 2022 | Jun, 2022 | Mar, 2022 | Sep, 2021 | Jun, 2021 |
| Sales | 240 | 181 | 210 | 73 | 38 |
| Sales Growth | +32.60% | -13.55% | +187.80% | +89.84% | -5.00% |
| Net Income | -309 | -588 | -516 | -6,756 | 3,403 |
| Net Income Growth | +47.34% | -13.84% | +92.36% | -298.50% | +608.58% |
Cbd Global Sciences Inc (CBDN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CBD Global Sciences Inc is a Canadian hemp-based CBD producer. The company is engaged in the business of producing and selling industrial hemp-derived Cannabidiol (CBD) infused consumable and topical products. It distributes products under two brands AETHICS and CANNAOIL. The revenue generated by the company includes sales of Cannabidiol products like hemp biomass, oil, and oil products.
Fiscal Year End Date: 12/31